M Bio Technology Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
M Bio Technology is a world leading company focused on R&D of innovative therapeutic strategy for Mycoplasma Infectious Diseases (MID). MID is a cause of fever, cough, interstitial pneumonia (MID is indistinguishable from COVID-19, Co-Infecion).

M Bio Technology Inc. develops innovative drug candidates, diagnostics, and therapeutic technologies: vaccine (MID Vaccine™), therapeutic antibody (MID Therapeutic antibody™), diagnostics (MID Prism®), precision therapy (MID Precision Medicine™) for Mycoplasma Infectious Diseases (MID).

Company Type:
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
2005
Main Therapeutic Focus:
Lead Product in Development:
Mycoplasma Vaccine, Therapeutic antibodies, Diagnostics and Platform technology
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President
M Bio Technology Inc.